Po Wang

Clinical Focus

• Psychiatry

Professional Education

• Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2001)
• Stanford University Medical Center (1999) CA
• Stanford University Medical Center (1996) CA
• Washington University School of Medicine (1995) MO

Web Site Links

• Bipolar Clinic Website

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. 

• Consulting: AstraZeneca, Bristol Meyers Squibb, GlaxoSmithKline

Publications

• Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depression. Brooks JO,  Bonner JC, Rosen AC, Wang PW, Hoblyn JC, Hill SJ, Ketter TA.  Psychiatry Res.  2009; 172 (3): 200-4
• Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. Brooks JO,  Wang PW, Bonner JC, Rosen AC, Hoblyn JC, Hill SJ, Ketter TA.  J Psychiatr Res.  2009; 43 (3): 181-8
• Insulin resistance and hyperlipidemia in women with bipolar disorder. Stemmle PG,  Kenna HA, Wang PW, Hill SJ, Ketter TA, Rasgon NL.  J Psychiatr Res.  2009; 43 (3): 341-3
• Divalproex extended-release in acute bipolar II depression. Wang PW,  Nowakowska C, Chandler RA, Hill SJ, Nam JY, Culver JL, Keller KL, Ketter TA.  J Affect Disord.  2009;
• A new US-UK diagnostic project: mood elevation and depression in first-year undergraduates at Oxford and Stanford universities. Chandler RA,  Wang PW, Ketter TA, Goodwin GM.  Acta Psychiatr Scand.  2008; 118 (1): 81-5
• Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study. Wang PW,  Yang YS, Chandler RA, Nowakowska C, Alarcon AM, Culver J, Ketter TA.  J Psychiatr Res.  2008; 42 (6): 451-7
• Improving the pedagogy associated with the teaching of psychopharmacology. Glick ID,  Salzman C, Cohen BM, Klein DF, Moutier C, Nasrallah HA, Ongur D, Wang P, Zisook S.  Acad Psychiatry.  2007 May-Jun; 31 (3): 211-7
• Enhanced creativity in bipolar disorder patients: a controlled study. Santosa CM,  Strong CM, Nowakowska C, Wang PW, Rennicke CM, Ketter TA.  J Affect Disord.  2007; 100 (1-3): 31-9
• Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individuals. Strong CM,  Nowakowska C, Santosa CM, Wang PW, Kraemer HC, Ketter TA.  J Affect Disord.  2007; 100 (1-3): 41-8
• Adjunctive aripiprazole in treatment-resistant bipolar depression. Ketter TA,  Wang PW, Chandler RA, Culver JL, Alarcon AM.  Ann Clin Psychiatry.  2006 Jul-Sep; 18 (3): 169-72
• Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls. Brooks JO,  Wang PW, Strong C, Sachs N, Hoblyn JC, Fenn R, Ketter TA.  Bipolar Disord.  2006; 8 (3): 248-54
• Overweight and obesity in bipolar disorders. Wang PW,  Sachs GS, Zarate CA, Marangell LB, Calabrese JR, Goldberg JF, Sagduyu K, Miyahara S, Ketter TA.  J Psychiatr Res.  2006; 40 (8): 762-4
• Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. Nowakowska C,  Strong CM, Santosa CM, Wang PW, Ketter TA.  J Affect Disord.  2005; 85 (1-2): 207-15
• Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash. Ketter TA,  Wang PW, Chandler RA, Alarcon AM, Becker OV, Nowakowska C, O'Keeffe CM, Schumacher MR.  J Clin Psychiatry.  2005; 66 (5): 642-5
• Clinical use of carbamazepine for bipolar disorders. Wang PW,  Ketter TA.  Expert Opin Pharmacother.  2005; 6 (16): 2887-902
• New medication treatment options for bipolar disorders. Ketter TA,  Wang PW, Nowakowska C, Marsh WK.  Acta Psychiatr Scand Suppl.  2004; (422): 18-33
• Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? Ketter TA,  Wang PW, Becker OV, Nowakowska C, Yang Y.  J Psychiatr Res.  2004; 38 (1): 47-61
• The diverse roles of anticonvulsants in bipolar disorders. Ketter TA,  Wang PW, Becker OV, Nowakowska C, Yang YS.  Ann Clin Psychiatry.  2003; 15 (2): 95-108
• The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders. Ketter TA,  Wang PW.  J Clin Psychiatry.  2003; 64 Suppl 3 15-20
• New anticonvulsant medication uses in bipolar disorder. Wang PW,  Ketter TA, Becker OV, Nowakowska C.  CNS Spectr.  2003; 8 (12): 930-2, 941-7
• Safety of antidepressants in the elderly. Sommer BR,  Fenn H, Pompei P, DeBattista C, Lembke A, Wang P, Flores B.  Expert Opin Drug Saf.  2003; 2 (4): 367-83
• Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. Janenawasin S,  Wang PW, Lembke A, Schumacher M, Das B, Santosa CM, Mongkolcheep J, Ketter TA.  Bipolar Disord.  2002; 4 (5): 328-34
• Gabapentin augmentation therapy in bipolar depression. Wang PW,  Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA.  Bipolar Disord.  2002; 4 (5): 296-301
• Pharmacokinetics of mood stabilizers and new anticonvulsants. Wang PW,  Ketter TA.  Psychopharmacol Bull.  2002; 36 (1): 44-66
• Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies. Ketter TA,  Wang PW.  J Clin Psychiatry.  2002; 63 Suppl 3 21-5
• Biology and recent brain imaging studies in affective psychoses. Wang PW,  Ketter TA.  Curr Psychiatry Rep.  2000; 2 (4): 298-304